The Valpharma Group makes available its own experience and technologies in favour of prospective partners interested in the research, development and industrial manufacture of:
- tablets or dragée in modified release form ( i.e. enteric coated, enteric coated plus slow release or slow release form);
- pellets (=beadlets, microspheres) for hard gelatine capsules in modified release form.
The development of the individual formulations includes the realization of the technical dossiers needed for the registrations with the Health Authorities worldwide.
Key Information
- Core Sales Territory:
Global Regulated Markets




